Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients

Hyperphosphatemia in chronic kidney disease (CKD) has been associated with elevated cardiovascular morbidity and mortality. Serum phosphate control remains a cornerstone of the clinical management of patients with CKD, in order to both attenuate the progression of secondary hyperparathyroidism or bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lenglet, Aurélie, Liabeuf, Sophie, Guffroy, Pauline, Fournier, Albert, Brazier, Michel, Massy, Ziad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784056/
https://www.ncbi.nlm.nih.gov/pubmed/24000048
http://dx.doi.org/10.1007/s40268-013-0024-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784056/
https://www.ncbi.nlm.nih.gov/pubmed/24000048
http://dx.doi.org/10.1007/s40268-013-0024-6

Ejemplares similares